Related references
Note: Only part of the references are listed.High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant
Helene Gellert-Kristensen et al.
HEPATOLOGY (2020)
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo et al.
CELL METABOLISM (2020)
Association of HSD17B13 rs72613567:TA with non-alcoholic fatty liver disease in Hispanics/Latinos
Eric Kallwitz et al.
LIVER INTERNATIONAL (2020)
PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice
Yang Wang et al.
HEPATOLOGY (2019)
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease
Jie Yang et al.
HEPATOLOGY (2019)
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
Soumik BasuRay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
Daniel Linden et al.
MOLECULAR METABOLISM (2019)
Towards Precision Medicine in Nonalcoholic Fatty Liver Disease with PNPLA3 as a Therapeutic Target
Massimo Colombo et al.
GASTROENTEROLOGY (2019)
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease
Yanling Ma et al.
HEPATOLOGY (2019)
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update
Ryosuke Tateishi et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression and recurrence of hepatocellular carcinoma
Jun Chen et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
N. S. Abul-Husn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression
Yuya Seko et al.
HEPATOLOGY RESEARCH (2017)
The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells
Francesca Virginia Bruschi et al.
HEPATOLOGY (2017)
The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
Soumik BasuRay et al.
HEPATOLOGY (2017)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Sumio Watanabe et al.
JOURNAL OF GASTROENTEROLOGY (2015)
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
Amit G. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
Carlo Pirazzi et al.
HUMAN MOLECULAR GENETICS (2014)
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
Yusuke Kawamura et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese
Takahisa Kawaguchi et al.
PLOS ONE (2012)
Clinicopathological features of non-alcoholic fatty liver disease
Kazushi Sugimoto et al.
HEPATOLOGY RESEARCH (2011)
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
John C. Chambers et al.
NATURE GENETICS (2011)
Genome-Wide Association Study Identifies Variants Associated With Histologic Features of Nonalcoholic Fatty Liver Disease
Naga Chalasani et al.
GASTROENTEROLOGY (2010)
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Anna Kotronen et al.
GASTROENTEROLOGY (2009)
Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes
Xin Yuan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
17β-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein
Yuka Horiguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
JM Hui et al.
HEPATOLOGY (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
